Nov 24 (Reuters) - Takeda Canada
* Canadian Drug Expert Committee issued positive listing recommendation for Entyvio for reimbursement by provincial drug plans
* Positive listing recommendation for Entyvio for treatment of adults with moderate to severely active Crohn's Disease Source text for Eikon: ID:nCNWB24kXa Further company coverage: 4502.T